GSK961081
GSK961081 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers
Succinate Salt Version of GSK961081 for Healthy Volunteers
Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination
A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients
A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical Trials (5)
A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers
Succinate Salt Version of GSK961081 for Healthy Volunteers
Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination
A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients
A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5